Request Discount
Infinium anniversary bonus, get Enterprise wide license report at the price of single user license till Q3 ends

Protein Therapeutics Market (Protein Function - Vaccines, Enzymatic and Regulatory, and Protein Diagnostics; Product Type - Insulin, Erythropoietin, Monoclonal Antibodies, G-CSF, Interferons, Follicle Stimulating Hormone, and Blood Clotting Factor): Global Industry Analysis, Trends, Size, Share and Forecasts to 2026

  • Published : December, 2020

  • Rep Id : HC0218

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on protein therapeutics market provides in-depth analysis of segments and sub-segments in the global as well as regional protein therapeutics market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional protein therapeutics market over the short term as well as long term. The report is a comprehensive presentation of trends, forecasts, and dollar values of the global protein therapeutics market. According to the report, the global protein therapeutics market is projected to grow at a CAGR of 6.24% over the forecast period of 2020-2026.

Over-the-Counter Drug Market

 

Market Insight

It allows for an individualized approach to treatment by promoting a specifically targeted therapeutic process by compensating for the deficiency of an essential protein. It also helps minimize the effects of illness or chemotherapy; it may also improve the body's supply of a beneficial protein. Therapeutic proteins are used to treat an extensive range of diseases such as protein deficiency diseases, rheumatoid arthritis (RA), diabetes, chronic diseases such as cancer, infections such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and hepatitis C; and other medical conditions such as genetic disorders, anemia cases related to kidney dialysis, and cancer-related anemia. Protein therapeutics mostly consist of recombinant forms of naturally occurring proteins. The COVID-19 outbreak and the containment measures introduced by the government have severely affected the drug development and pharmaceutical sector. The virus has brought many uncertainties such as supply chain disruption, and raw material unavailability owing to stringent government regulations. However, Molecular Partners AG, a Switzerland-based clinical-stage biotechnology organization, is developing another class of protein therapeutics, called DARPin, to restrain the multiplication of the infection. Therefore, the unexpected occurrence of the COVID-19 will further providing development opportunities for the market players in the upcoming years.


Advancements in biological sciences have shown a positive influence on the global protein therapeutics market. There are novel technological advancements in terms of drug manufacture, development, and delivery. Also, the future landscape of the market is expected to be promising as there are novel products in the pipeline that are expected to revolutionize the market globally. However, protein therapeutics are expensive and cannot be afforded by all, but reimbursement of diagnostic kits and biologic drugs is expected to fuel the market during the forecast period. The increasing demand for costly drugs is an important reason for these drugs to be included in reimbursement plans. Plans such as public reimbursement programs reduce the financial burden of treatments and driving the demand for these therapeutics. On the other hand, complexities in manufacturing, storage conditions, and distribution policies affect the growth of the market. Nevertheless, the increasing usage of next-generation mAbs in treating diseases will have a positive impact on the market.


Among the regions, North America holds a major share in the global protein therapeutics market. The US is a key revenue generator in the North American protein therapeutics market. Factors such as the rising prevalence of cardiovascular diseases and the presence of major key players in this region increase demand for the protein therapeutics market. Further, Asia Pacific will witness rapid growth in the forecast period owing to the increasing purchasing power of consumers and rapid growth in the healthcare sector in emerging countries such as China, Japan, and India.

 

Segment Covered

The report on the global protein therapeutics market covers segments such as protein function and product type. On the basis of protein function, the sub-markets include vaccines, enzymatic and regulatory, and protein diagnostics. On the basis of product type, the sub-markets include insulin, erythropoietin, monoclonal antibodies, G-CSF, interferons, follicle stimulating hormone, and blood clotting factor.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Baxter International, F. Hoffmann-La Roche, Merck, AbbVie, Eli Lilly, Generex Biotechnology, Amgen, Novo Nordisk, Johnson & Johnson, and Pfizer.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the protein therapeutics market. Moreover, the study highlights current market trends and provides forecasts from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount